Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More
Pillsy has launched a subscription service that works alongside the Seattle-based startup’s smart pill bottles, reminding users to take their supplements… Read More
Sorting through and analyzing medical records is incredibly time-consuming, limiting the ability of patients, doctors and administrators to make connections and… Read More
Medical researchers know all about the blood-brain barrier, but Seattle’s Allen Institute and the American Heart Association have selected three… Read More
Zymogenetics, the Seattle-based pharmaceutical company owned by Bristol-Myers Squibb, will start the process of laying off workers and closing its… Read More